Literature DB >> 10966924

Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney.

X Wu1, W Huang, M E Ganapathy, H Wang, R Kekuda, S J Conway, F H Leibach, V Ganapathy.   

Abstract

We examined in this study the expression of the potential-sensitive organic cation transporter OCT3 in the kidney. A functionally active OCT3 was cloned from a mouse kidney cDNA library. The cloned transporter was found to be capable of mediating potential-dependent transport of a variety of organic cations including tetraethylammonium. This function was confirmed in two different heterologous expression systems involving mammalian cells and Xenopus laevis oocytes. We have also isolated the mouse OCT3 gene and deduced its structure and organization. The OCT3 gene consists of 11 exons and 10 introns. In situ hybridization studies in the mouse kidney have shown that OCT3 mRNA is expressed primarily in the cortex. The expression is evident in the proximal and distal convoluted tubules. The expression of OCT3 in human kidney was confirmed by RT-PCR. We have also cloned OCT3 from human placenta and human kidney. Human OCT3 exhibits 86% identity with mouse OCT3 in amino acid sequence. Human OCT3 was found to transport tetraethylammonium and a variety of other organic cations. The transport process was electrogenic. We conclude that OCT3 is expressed in mammalian kidney and that it plays an important role in the renal clearance of cationic drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966924     DOI: 10.1152/ajprenal.2000.279.3.F449

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  34 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon.

Authors:  Sudha Ananth; Lina Zhuang; Elangovan Gopal; Shiro Itagaki; Babu Ellappan; Sylvia B Smith; Vadivel Ganapathy; Pamela Martin
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

Review 3.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.

Authors:  Dustin R Walsh; Thomas D Nolin; Peter A Friedman
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

5.  Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells.

Authors:  Dirk Gründemann; Ann-Cathrin Koschker; Christine Haag; Cornelius Honold; Tim Zimmermann; Edgar Schömig
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

6.  Organic cation transporter variation and response to smoking cessation therapies.

Authors:  Andrew W Bergen; Harold S Javitz; Ruth Krasnow; Martha Michel; Denise Nishita; David V Conti; Christopher K Edlund; Pui-Yan Kwok; Jennifer B McClure; Richard B Kim; Sharon M Hall; Rachel F Tyndale; Timothy B Baker; Neal L Benowitz; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2014-08-20       Impact factor: 4.244

Review 7.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 8.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

9.  Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.

Authors:  Aditi Mulgaonkar; Jürgen Venitz; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

10.  Expression and immunolocalization of the plasma membrane monoamine transporter in the brain.

Authors:  A Dahlin; L Xia; W Kong; R Hevner; J Wang
Journal:  Neuroscience       Date:  2007-04-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.